The Potent and Selective Oral STAT6 Degrader, KT-621, Affects Gene Transcripts in Human Keratinocytes as Effectively as Dupilumab, and Blocks Th2 Inflammation in Atopic Dermatitis and Asthma Mouse Models. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 25];9(6):s629. Available from: https://skin.dermsquared.com/skin/article/view/3899